Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-09-02
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, 514460, 514547, A61K 3141, A61K 3135, A61K 3140
Patent
active
056631863
ABSTRACT:
A method of treatment for atherosclerosis and/or reducing cholesterol using an angiotensin II antagonist. This method of treatment can be used in conjunction with the treatment of hypertension. Substituted imidazoles such as ##STR1## are useful as angiotensin II receptor antagonists for this method of treatment. A method of treatment for atherosclerosis and/or reducing cholesterol using an angiotensin II receptor antagonist in combination with an HMG-Co A reductase inhibitor. A method of treatment for atherosclerosis and/or reducing cholesterol using an angiotensin II receptor antagonist in combination with an HMG-Co A reductase inhibitor and an angiotensin converting enzyme inhibitor. Also within the scope of this invention are pharmaceutical compositions for this method of use.
REFERENCES:
patent: 4374829 (1983-02-01), Harris et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 5138069 (1992-08-01), Carini et al.
patent: 5162340 (1992-11-01), Chakravarty et al.
patent: 5214153 (1993-05-01), Chen et al.
patent: 5218125 (1993-06-01), Chen et al.
patent: 5225428 (1993-07-01), Kramer et al.
Mol et al., "Effects of Synuinolin (MK-733) on Plasma Lipidsin Familial Hypercholesterolaemia," The Lancet, Oct. 25, 1986, pp. 936-939.
The Merck Manual, 1987, 15th Edition pp. 386-389.
Nelson Edward B.
Sweet Charles S.
Camara Valerie J.
Cebulak M.
Daniel Mark R.
Merck & Co. , Inc.
Raymond Richard L.
LandOfFree
Treatment of atherosclerosis with angiotensin II receptor blocki does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of atherosclerosis with angiotensin II receptor blocki, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of atherosclerosis with angiotensin II receptor blocki will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308543